ペプチド–薬物およびペプチド–タンパク質コンジュゲート
技術範囲、品質レベル、バッチ文書、納品要件はプロジェクトの段階に応じて設定できます。
生物学研究および産業用途を目的としており、個人の臨床用途または医療用途を意図したものではありません。
標的デリバリー、トラッキング、機能解析、創薬開発に向けた高度なペプチドコンジュゲーション。
中核技術
PEG・脂質・色素・同位体・ビオチンとのコンジュゲーション
技術範囲、品質レベル、バッチ文書、納品要件はプロジェクトの段階に応じて設定できます。
クリックケミストリーとチオール–マレイミド戦略
技術範囲、品質レベル、バッチ文書、納品要件はプロジェクトの段階に応じて設定できます。
切断型・非切断型リンカーシステム
技術範囲、品質レベル、バッチ文書、納品要件はプロジェクトの段階に応じて設定できます。
標準的な流れ
1要件確認
2技術的実現性
3見積とスケジュール
4合成またはプロセス実行
5QC 文書
6出荷とフォローアップ
| 開発段階 | ペプチドサポート |
|---|---|
| コンセプトと実現性 | ペプチド設計戦略、配列最適化、実現性評価 |
| 探索研究 | カスタムペプチド合成、ターゲティングペプチド設計、機能スクリーニング支援 |
| リード最適化 | ペプチド修飾、コンジュゲーション戦略、構造活性最適化 |
| プロセス開発 | 合成ルート最適化、プロセス頑健性、不純物管理戦略 |
| GMP 製造 | GMP 準拠のペプチド合成、品質文書、バッチ出荷判定の支援 |
技術ノート
Maleimide and thiol coupling
The reaction between a maleimide and a free thiol is the workhorse of peptide conjugation: fast, high-yielding, and selective for cysteine at mildly acidic to neutral pH. Above roughly pH 7.5 the maleimide begins to react with amines as well and selectivity is lost. The peptide's cysteine must be free rather than already in a disulfide, so material stored without a reducing agent may need reduction and clean-up before coupling. The resulting thioether is stable, though it can slowly exchange with other thiols in complex biological media.
NHS ester and amine coupling
N-hydroxysuccinimide esters acylate primary amines, meaning the peptide N-terminus and every lysine side chain. That makes the chemistry easy and the product heterogeneous unless there is only one amine present. The reagent also hydrolyses in water in competition with the coupling, so buffer choice matters and amine-containing buffers such as Tris cannot be used. Where site-specificity is required, either the peptide is designed with a single available amine or a thiol-based route is used instead.
Click chemistry
Azide-alkyne cycloaddition is bio-orthogonal: neither partner reacts with anything normally present on a peptide, so the coupling site is defined entirely by where the handle was installed. Copper-catalysed reactions are efficient but the catalyst can damage sensitive residues and must be removed afterwards. Strain-promoted reactions using cyclooctyne reagents avoid copper altogether at the cost of a larger, more hydrophobic handle. Both require the handle to be introduced during synthesis, so this route is chosen at the design stage rather than later.
Carrier proteins and hapten density
KLH is the usual carrier for immunisation because of its size and immunogenicity, and BSA or ovalbumin are used for the screening assay so that anti-carrier antibodies do not appear as false positives. Hapten density, the average number of peptides per carrier, influences the response: too low gives weak immunogenicity, too high can mask the peptide or reduce carrier solubility. Density is estimated after conjugation rather than assumed from the input ratio.
Characterising a conjugate
Conjugates are heterogeneous by nature, so characterisation describes a distribution rather than a single species. Dye-to-peptide ratio is calculated from absorbance at the dye maximum and the peptide, with a correction for the dye's own absorbance in the peptide region. Peptide-to-carrier ratio for protein conjugates is estimated by mass shift, amino acid analysis or a reagent-specific assay. Free, unconjugated payload is removed by desalting, dialysis or chromatography, and confirming its absence is part of release rather than an optional extra.
納品物
- Conjugate purified from unreacted peptide and free payload
- Ratio data appropriate to the conjugate type, such as dye-to-peptide or hapten density
- Analytical confirmation of the conjugation chemistry as executed
- Description of the linker, attachment site and coupling conditions used
- Handling and storage guidance for the conjugate as supplied
主な用途
Antibody generation — Peptide-carrier immunogens with a matched screening conjugate on a different carrier, so that the assay measures anti-peptide rather than anti-carrier response.
Imaging and detection probes — Dye or biotin conjugates for microscopy, flow cytometry and capture assays, with the ratio characterised and the attachment site chosen away from the binding face.
Targeted delivery constructs — Peptide-payload conjugates where the linker is chosen for whether and where the payload is intended to be released.
Surface immobilisation — Conjugates designed for attachment to beads, plates or sensor surfaces, where linker length and orientation determine whether the peptide remains accessible.
よくあるご質問
Which carrier protein should I use for antibody production?
KLH is the usual choice for immunisation because its size and immunogenicity give a strong response. Use a different carrier, commonly BSA or ovalbumin, for the screening assay. If both use the same carrier, antibodies raised against the carrier will appear as positives and the screen will not tell you what you need to know.
Where should the conjugation site go?
Away from the region that has to stay recognisable. For an epitope peptide that usually means adding a cysteine at whichever terminus is not part of the epitope. Where the peptide corresponds to an internal region of a protein, the terminus that faced into the protein is generally the safer attachment point.
My peptide has no cysteine. Can it still be conjugated?
Yes. A cysteine can be added at either terminus during synthesis, which is the cleanest option and keeps the site defined. Alternatively, amine-directed chemistry can be used, though with several lysines present the product will be a mixture of attachment sites. If the sequence has not been made yet, adding the handle at the design stage is much the better route.
How is the dye-to-peptide ratio determined?
From absorbance measurements at the dye maximum and in the peptide region, applying the dye's correction factor for its absorbance at the peptide wavelength. Skipping that correction systematically overstates the peptide concentration and therefore understates the ratio.
Should the linker be cleavable?
Only if the payload has to be released. A cleavable linker adds a failure mode, since premature release lowers what reaches the target and can cause effects where it is not wanted. For imaging and detection, where the payload should stay attached, a stable linker is the appropriate choice.
How do I know free dye has been removed?
Unconjugated payload is removed by desalting, dialysis or chromatography depending on the size difference, and its absence is confirmed analytically rather than assumed from the clean-up step. Residual free dye is a common cause of high background, and it is worth confirming before an unexplained background is attributed to the biology.
関連ペプチド製品
単一ペプチド
単一ペプチド製品の全カタログをご覧いただけます。見積は問い合わせベースです。
続きを読むMazdutide（5 mg バイアル）
本リファレンスはバイアル形態の Mazdutide（5 mg バイアル） を扱います。溶解手順、液量ごとに得られる濃度、シリンジ単位への換算、凍結乾燥品および溶解後の材料の保管条件を含みます。
続きを読むNAD+（500 mg バイアル）
NAD+（500 mg バイアル） の溶解および取り扱いリファレンスです。加える静菌水の量、それにより得られる濃度、用量から U-100 シリンジ単位への換算、溶解前後のバイアルの保管方法を示します。
続きを読むOxytocin（5 mg バイアル）
凍結乾燥品として供給される Oxytocin（5 mg バイアル） の取り扱いに関する注意事項です。溶解液量と得られる濃度、U-100 シリンジ単位への換算、プロトコルごとの消耗品数、保管条件を扱います。
続きを読む